Chemical and Pharmaceutical Bulletin p. 1858 - 1864 (1996)
Update date:2022-08-05
Topics:
Take, Kazuhiko
Okumura, Kazuo
Tsubaki, Kazunori
Taniguchi, Kiyoshi
Terai, Takao
Shiokawa, Youichi
N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine ((±)-3) was designed to restrict the conformation of terodiline I and was synthesized in a 6-step approach starting with diphenylacetaldehyde (10) or in a 4-step approach starting with 2,2-diphenyl-4-pentenoi
View MoreShandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Shanghai united Scientific Co.,Ltd.
Contact:+86-21-53535353
Address:28F No.900 huaihai Road Shanghai China
Zhejiang Quzhou Zhengbang Organosilicon Co.,ltd.
Contact:86-570-3375195
Address:No.17 Lingqing Road technology industry,Quzhou City,Zhejiang Province,China
Contact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
website:http://www.eastarchem.com/
Contact:1-800-898-2436
Address:1215 K Street, STE 1700
Doi:10.1039/a806200e
(1998)Doi:10.1021/jo00926a009
(1974)Doi:10.1021/jo00926a028
(1974)Doi:10.1246/bcsj.50.3417
(1977)Doi:10.1021/jo00322a047
(1981)Doi:10.1016/S0022-328X(00)86537-7
(1973)
